Highlights

  • Ansell Ltd (ASX: ANN) traded at $34.45 as at 3:00pm AEST on August 7, 2026.
  • The stock recorded a decline of approximately 0.35 percent for the session based on the data reviewed.
  • Shares traded within an intraday range of $34.08 to $34.60.
  • Market capitalisation stood at approximately $4.83 billion.
  • Trading volume reached 102,819 shares during the session.

Ansell Ltd (ASX: ANN) shares were trading at $34.45 as at 3:00pm AEST on August 7, 2026, after recording a decline of approximately 0.35 percent during the session. The stock traded within an intraday range of $34.08 to $34.60, while the broader S&P/ASX 200 Health Care Index moved lower during the same period.

Ansell Share Price Movement on August 7, 2026

The data reviewed showed that Ansell shares recorded a decline of approximately 0.35 percent for the session. The stock moved between an intraday low of $34.08 and a high of $34.60.

The daily movement represented a relatively contained change compared with the broader price range recorded during the session. Share price movements can be influenced by company-specific developments, market participation, sector sentiment and broader economic conditions.

Trading Volume and Market Capitalisation

Trading volume for Ansell reached 102,819 shares during the session. Based on the reported share price, the company’s market capitalisation stood at approximately $4.83 billion.

The trading activity reflected participation in the stock during the reviewed period, while the market capitalisation placed Ansell among the larger companies within the S&P/ASX 200 Health Care Index.

One-Year Share Price Performance

Over the trailing one-year period, Ansell recorded an increase of approximately 10.95 percent based on the data reviewed.

The company’s annual share price performance differed from the broader health care index, which recorded a negative one-year return over the same period. Individual company performance can vary depending on company-specific factors, operational developments and wider market conditions.

ASX Health Care Sector Performance

The broader S&P/ASX 200 Health Care Index (XHJ) was trading at 28,010.8 points, down 224.7 points or 0.80 percent, as at 3:20pm AEST on August 7, 2026, with the market session still open.

The index traded within an intraday range of 27,808.8 to 28,235.5 points against a previous close of 28,235.5. Over the past 52 weeks, the index ranged between 21,947.2 and 45,579.6 points, with a one-year return of negative 37.37 percent.

Individual companies within the health care sector can experience movements that differ from the broader index due to company-specific factors, trading activity and investor sentiment.

About Ansell Ltd

Ansell Ltd is a company operating within the personal protection segment of the health care sector and is listed on the ASX under the ticker code ANN.

The company is included within the S&P/ASX 200 Health Care Index, and its share price activity can be influenced by company developments, sector conditions and broader market movements.

Understanding the Trading Data

The share price, trading volume and market capitalisation figures provide an overview of Ansell’s market activity during the reviewed session.

Trading volume represents the number of shares exchanged during the period, while market capitalisation reflects the market value based on the reported share price and shares on issue. Daily share price movements represent activity during a specific timeframe and should be considered alongside longer-term performance and broader market conditions.

Conclusion

As at 3:00pm AEST on August 7, 2026, Ansell Ltd (ASX: ANN) shares were trading at $34.45, within a day range of $34.08 to $34.60, on trading volume of 102,819 shares and a market capitalisation of approximately $4.83 billion.

The stock recorded a decline of approximately 0.35 percent during the session, while the broader S&P/ASX 200 Health Care Index also traded lower. Over the trailing one-year period, Ansell recorded an increase of approximately 10.95 percent based on the data reviewed.